Mezrich Joshua D, Yamada Kazuhiko, Lee Richard S, Mawulawde Kwabena, Benjamin Louis C, Schwarze Margaret L, Maloney Michaella E, Amoah Hannah C, Houser Stuart L, Sachs David H, Madsen Joren C
Transplantation Biology Research Center, Massachusetts General Hospital, Boston, MA 02114, USA.
Transplantation. 2003 Aug 27;76(4):625-31. doi: 10.1097/01.TP.0000079926.80833.42.
To determine the mechanism by which cotransplantation of a donor kidney and heart allograft induces tolerance to both organs in miniature swine, we examined the renal elements responsible for tolerance induction.
Recipients received 12 days of cyclosporine, and transplants were performed across a major histocompatibility complex (MHC) class I mismatch. Group 1 animals received heart transplants (n=5); group 2 animals received heart and kidney allografts with no other manipulation (n=4); group 3 animals received heart transplants and donor-specific renal parenchymal cells (n=4); group 4 animals received heart and kidney allografts from lethally irradiated donors (n=7); group 5 animals received irradiated hearts and nonirradiated kidneys (n=2); group 6 animals received nonirradiated hearts and peripheral blood leukocytes from swine MHC matched to recipients and becoming tolerant to donor antigen (n=2); group 7 animals received nonirradiated hearts and donor-specific peripheral blood monocyte cells (PBMC) (n=2).
Animals in group 1 developed vasculopathy and fulminant rejection by day 55. Animals in group 2 never developed vascular lesions. Parenchymal kidney cell infusion (group 3) did not prolong cardiac survival. Animals in group 4 developed arteriopathy by postoperative day (POD) 28. Group 5 recipients accepted allografts without vascular lesions. Adoptive transfer of leukocytes from tolerant swine (group 6) prolonged cardiac graft survival as much as 123 days, whereas donor PBMC infusion (group 7) did not affect cardiac survival or development of arteriopathy.
Radiosensitive elements in kidney allograft may be responsible for tolerance induction and prevention of chronic vascular lesions in recipients of simultaneous heart and kidney allografts.
为确定供体肾脏和心脏同种异体移植物联合移植诱导小型猪对两种器官产生耐受的机制,我们研究了负责诱导耐受的肾脏因素。
受体接受12天的环孢素治疗,并进行主要组织相容性复合体(MHC)Ⅰ类错配的移植。第1组动物接受心脏移植(n = 5);第2组动物接受心脏和肾脏同种异体移植,未进行其他处理(n = 4);第3组动物接受心脏移植和供体特异性肾实质细胞(n = 4);第4组动物接受来自致死性照射供体的心脏和肾脏同种异体移植(n = 7);第5组动物接受照射的心脏和未照射的肾脏(n = 2);第6组动物接受未照射的心脏和与受体猪MHC匹配且对供体抗原产生耐受的外周血白细胞(n = 2);第7组动物接受未照射的心脏和供体特异性外周血单核细胞(PBMC)(n = 2)。
第1组动物在第55天时出现血管病变和暴发性排斥反应。第2组动物从未出现血管病变。肾实质细胞输注(第3组)未延长心脏存活时间。第4组动物在术后第28天出现动脉病变。第5组受体接受同种异体移植,未出现血管病变。来自耐受猪的白细胞过继转移(第6组)使心脏移植物存活时间延长多达123天,而供体PBMC输注(第7组)对心脏存活或动脉病变的发展没有影响。
肾脏同种异体移植物中的放射敏感成分可能是同时进行心脏和肾脏同种异体移植的受体诱导耐受和预防慢性血管病变的原因。